Donald Notman | Chief Financial Officer |
Antony Mattessich | President and Chief Executive Officer |
Michael Goldstein | Chief Medical Officer |
Scott Corning | Senior Vice President, Commercial |
Daniel Bollag | Senior Vice President, Regulatory Affairs |
Adnan Butt | Guggenheim Securities |
Donald Ellis | JMP Securities |
Yi Chen | H.C. Wainwright & Co |
Joseph Pratt | Stifel, Nicolaus & Company |
Joseph Catanzaro | Piper Jaffray |
Good afternoon, ladies and gentlemen, thank you for standing by. And welcome to the Ocular Therapeutix Third Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. It is now my pleasure to turn the call over to Donald Notman, Chief Financial Officer of Ocular Therapeutix.